Editor’s note: Last week Formation 8 announced it raised $500 million for its second fund. This profile of the San Francisco-based venture, which already has a monster exit with Oculus VR, previously ran in the July 2014 issue of VCJ
Healthcare investors, like Versant and others, are looking at plenty of ophthalmic deals and exits
The volume of venture-backed initial public offerings slowed in the third quarter from the prior quarter, while acquisitions with disclosed dollar amounts came in higher.
For some LPs it’s crucial to avoid any appearance of impropriety. That means refusing lavish gifts, and it could extend as far as turning down a cup of coffee.
Silicon Valley firm is seeking $275 million for a planned Fund XI.
Industry Ventures has closed its third venture capital fund-of-funds with $170 million in committed capital after raising the cap a few times during fundraising.
Lux Capital, among others, sees a range of investment opportunities tied to drone industry
Silicon Valley firm is seeking $275 million for a planned Fund XI
No one wants a shotgun wedding over a term sheet, so it’s advisable to take a few weeks to get to know one another
There’s something to be said for sticking with a job. It certainly has worked out for Jim Breyer, who joined Accel Partners as a newly minted MBA graduate in 1987. It was a good call, Venture Capital Journal reports.
Too early to tell, but Trinity, Khosla and Upfront each have funds from the era that are breaking away from the pack
Technology lender Golub Capital is expanding its late stage lending platform with the addition of two investment directors and the opening of a new San Francisco office. The full announcement is below. GOLUB CAPITAL OPENS SAN FRANCISCO OFFICE AS PART OF ITS EXPANSION INTO LATE STAGE LENDING NEW YORK – September 16, 2014 – Golub […]
Avelas Biosciences, an in vivo cancer diagnostic company for oncologic surgeries, announced that it has closed on the second tranche of its Series B financing bringing the total funds raised in the round to $7.4 million. Participants in the financing included founding investor, Avalon Ventures, as well as existing investors Torrey Pines Investment, WuXi PharmaTech Investments, […]
Darwin Ventures, a fund-of-funds focused on early-stage deals, is seeking to raise up to $100 million for a third vehicle.
Venture firm DCM is seeking to raise $170 million for a dedicated China fund, according to a securities filing.
Investors back big rounds for therapy and tool developers.
Life science startups raise big rounds quickly, as cancer-fighting Juno collects $300 million in under a year.
The Accel Partners veteran is the recipient of VCJ’s Lifetime Achievement Award at September’s PartnerConnect conference in New York. But there are still plenty of chapters yet to be written in his investment career.